BFC Planning’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding GLSI
BFC Planning's GLSI Position: Q3 2026 in Review
BFC Planning reduced its Greenwich LifeSciences (GLSI) stake by 9.3% in Q3 2026, selling an estimated $3.33K and leaving 1,950 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1735.
BFC Planning first reported a position in GLSI in Q3 2024 and has held it in 9 quarters since. The position peaked at $51.6K in Q1 2026. 41 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.
- BFC Planning held 1,950 shares of Greenwich LifeSciences worth $35.2K as of Q3 2026.
- BFC Planning sold 200 Greenwich LifeSciences shares in Q3 2026, an estimated $3.33K.
- Greenwich LifeSciences made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1735 holding.
- BFC Planning first reported a position in Greenwich LifeSciences in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Greenwich LifeSciences position peaked at $51.6K in Q1 2026.
- 41 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.